Expression of mu opioid receptor in dorsal diencephalic conduction system: New insights for the medial habenula

Neuroscience

Volumn 277, Issue , 2014, Pages 595-609

  Gardon, O ^a   Faget, L ^a   Chu Sin Chung, P ^a   Matifas, A ^a   Massotte, D ^a   Kieffer, B L ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Acetylcholine; Interpeduncular nucleus; Knock in mice; Medial habenula; Mu opioid receptor; Substance P

Indexed keywords

MU OPIATE RECEPTOR; PREPROENKEPHALIN; SUBSTANCE P; VESICULAR GLUTAMATE TRANSPORTER 2; ACETYLCHOLINE; ENKEPHALIN; PHOTOPROTEIN; PROTEIN PRECURSOR; RED FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CHOLINERGIC NERVE CELL; DIENCEPHALON; DORSAL DIENCEPHALIC CONDUCTION; FEMALE; FLUORESCENCE; GLUTAMATERGIC TRANSMISSION; HABENULA; HABENULOINTERPEDUNCULAR TRACT; INTERPEDUNCULAR NUCLEUS CENTRAL SUBNUCLEUS; INTERPEDUNCULAR NUCLEUS INTERMEDIATE SUBNUCLEUS; INTERPEDUNCULAR NUCLEUS LATERAL SUBNUCLEUS; INTERPEDUNCULAR NUCLEUS ROSTRAL SUBNUCLEUS; MALE; MOUSE; MOUSE STRAIN; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SP NEURON; ANTERIOR COMMISSURE; CELL POPULATION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FASCICULUS RETROFLEXUS; IMAGE ANALYSIS; INTERPEDUNCULAR NUCLEUS; LATERAL HABENULA; MEDIAL HABENULA; NERVE CONDUCTION; PROTEIN TRANSPORT; TEGMENTUM; 129 MOUSE; ANIMAL; C57BL MOUSE; GENE TARGETING; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NERVE TRACT; TRANSGENIC MOUSE;

ACETYLCHOLINE; ANIMALS; ENKEPHALINS; FEMALE; GENE KNOCK-IN TECHNIQUES; HABENULA; IMMUNOHISTOCHEMISTRY; INTERPEDUNCULAR NUCLEUS; LUMINESCENT PROTEINS; MALE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURAL PATHWAYS; NEURONS; PROTEIN PRECURSORS; RECEPTORS, OPIOID, MU; SUBSTANCE P;

EID: 84907020125     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.07.053     Document Type: Article

References (91)

1. Aizawa H., Kobayashi M., Tanaka S., Fukai T., Okamoto H. Molecular characterization of the subnuclei in rat habenula. J Comp Neurol 2012, 520. Spc1.
2. Beaudry H., Dubois D., Gendron L. Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli. J Neurosci 2011, 31:13068-13077.
3. Bianco I.H., Wilson S.W. The habenular nuclei: a conserved asymmetric relay station in the vertebrate brain. Philos Trans R Soc Lond B Biol Sci 2009, 364:1005-1020.
4. Bilkei-Gorzo A., Berner J., Zimmermann J., Wickstrom R., Racz I., Zimmer A. Increased morphine analgesia and reduced side effects in mice lacking the tac1 gene. Br J Pharmacol 2010, 160:1443-1452.
5. Brinschwitz K., Dittgen A., Madai V.I., Lommel R., Geisler S., Veh R.W. Glutamatergic axons from the lateral habenula mainly terminate on GABAergic neurons of the ventral midbrain. Neuroscience 2010, 168:463-476.
6. Buccafusco J.J., Shuster L.C. Effect of intrathecal pretreatment with the neurokinin receptor antagonist CP-99994 on the expression of naloxone-precipitated morphine withdrawal symptoms. Brain Res Bull 1997, 43:321-326.
7. Changeux J.P. Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nat Rev Neurosci 2010, 11:389-401.
8. Charbogne P., Kieffer B.L., Befort K. 15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacology 2014, 76(Pt B):204-217.
9. Chen W., McRoberts J.A., Marvizon J.C. mu-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain. Neuroscience 2014.
10. Contestabile A., Villani L., Fasolo A., Franzoni M.F., Gribaudo L., Oktedalen O., Fonnum F. Topography of cholinergic and substance P pathways in the habenulo-interpeduncular system of the rat. An immunocytochemical and microchemical approach. Neuroscience 1987, 21:253-270.
11. Cornwall J., Cooper J.D., Phillipson O.T. Afferent and efferent connections of the laterodorsal tegmental nucleus in the rat. Brain Res Bull 1990, 25:271-284.
12. Cuello A.C., Galfre G., Milstein C. Detection of substance P in the central nervous system by a monoclonal antibody. Proc Natl Acad Sci U S A 1979, 76:3532-3536.
13. Cuello A.C., Milstein C., Priestley J.V. Use of monoclonal antibodies in immunocytochemistry with special reference to the central nervous system. Brain Res Bull 1980, 5:575-587.
14. Dani J.A., De Biasi M. Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal. Cold Spring Harb Perspect Med 2013, 3.
15. Dao D.Q., Perez E.E., Teng Y., Dani J.A., De Biasi M. Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling. J Neurosci 2014, 34:4273-4284.
16. Darcq E., Befort K., Koebel P., Pannetier S., Mahoney M.K., Gaveriaux-Ruff C., Hanauer A., Kieffer B.L. RSK2 signaling in medial habenula contributes to acute morphine analgesia. Neuropsychopharmacology 2012, 37:1288-1296.
17. Darcq E., Koebel P., Del Boca C., Pannetier S., Kirstetter A.S., Garnier J.M., Hanauer A., Befort K., Kieffer B.L. RSK2 signaling in brain habenula contributes to place aversion learning. Learn Mem 2011, 18:574-578.
18. Erbs E., Faget L., Scherrer G., Kessler P., Hentsch D., Vonesch J.L., Matifas A., Kieffer B.L., Massotte D. Distribution of delta opioid receptor-expressing neurons in the mouse hippocampus. Neuroscience 2012, 221:203-213.
19. Erbs E., Faget L., Scherrer G., Matifas A., Filliol D., Vonesch J.L., Koch M., Kessler P., Hentsch D., Birling M.C., Koutsourakis M., Vasseur L., Veinante P., Kieffer B.L., Massotte D. A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks. Brain Struct Funct 2014.
20. Fusco F.R., Martorana A., De March Z., Viscomi M.T., Sancesario G., Bernardi G. Huntingtin distribution among striatal output neurons of normal rat brain. Neurosci Lett 2003, 339:53-56.
21. Gackenheimer S.L., Suter T.M., Pintar J.E., Quimby S.J., Wheeler W.J., Mitch C.H., Gehlert D.R., Statnick M.A. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites. Neuropeptides 2005, 39:559-567.
22. Geisler S., Trimble M. The lateral habenula: no longer neglected. CNS Spectr 2008, 13:484-489.
23. George S.R., Zastawny R.L., Briones-Urbina R., Cheng R., Nguyen T., Heiber M., Kouvelas A., Chan A.S., O'Dowd B.F. Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem Biophys Res Commun 1994, 205:1438-1444.
24. Goody R.J., Oakley S.M., Filliol D., Kieffer B.L., Kitchen I. Quantitative autoradiographic mapping of opioid receptors in the brain of delta-opioid receptor gene knockout mice. Brain Res 2002, 945:9-19.
25. Goutagny R., Loureiro M., Jackson J., Chaumont J., Williams S., Isope P., Kelche C., Cassel J.C., Lecourtier L. Interactions between the Lateral Habenula and the Hippocampus: implication for Spatial Memory Processes. Neuropsychopharmacology 2013.
26. Grady S.R., Moretti M., Zoli M., Marks M.J., Zanardi A., Pucci L., Clementi F., Gotti C. Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release. J Neurosci 2009, 29:2272-2282.
27. Groenewegen H.J., Ahlenius S., Haber S.N., Kowall N.W., Nauta W.J. Cytoarchitecture, fiber connections, and some histochemical aspects of the interpeduncular nucleus in the rat. J Comp Neurol 1986, 249:65-102.
28. Gu G., Kondo I., Hua X.Y., Yaksh T.L. Resting and evoked spinal substance P release during chronic intrathecal morphine infusion: parallels with tolerance and dependence. J Pharmacol Exp Ther 2005, 314:1362-1369.
29. Herzog E., Bellenchi G.C., Gras C., Bernard V., Ravassard P., Bedet C., Gasnier B., Giros B., El Mestikawy S. The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J Neurosci 2001, 21:RC181.
30. Hikosaka O. The habenula: from stress evasion to value-based decision-making. Nat Rev Neurosci 2010, 11:503-513.
31. Hikosaka O., Sesack S.R., Lecourtier L., Shepard P.D. Habenula: crossroad between the basal ganglia and the limbic system. J Neurosci 2008, 28:11825-11829.
32. Hnasko T.S., Edwards R.H. Neurotransmitter corelease: mechanism and physiological role. Annu Rev Physiol 2012, 74:225-243.
33. Ikemoto S. Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci Biobehav Rev 2010, 35:129-150.
34. Ilango A., Shumake J., Wetzel W., Scheich H., Ohl F.W. Electrical stimulation of lateral habenula during learning: frequency-dependent effects on acquisition but not retrieval of a two-way active avoidance response. PLoS One 2013, 8:e65684.
35. Jhou T.C., Geisler S., Marinelli M., Degarmo B.A., Zahm D.S. The mesopontine rostromedial tegmental nucleus: a structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta. J Comp Neurol 2009, 513:566-596.
36. Johnston P.A., Chahl L.A. Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs. Naunyn Schmiedebergs Arch Pharmacol 1991, 343:283-288.
37. Kalivas P.W. Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon. Neurosci Biobehav Rev 1985, 9:573-587.
38. Kaufling J., Veinante P., Pawlowski S.A., Freund-Mercier M.J., Barrot M. Afferents to the GABAergic tail of the ventral tegmental area in the rat. J Comp Neurol 2009, 513:597-621.
39. Kawaja M.D., Flumerfelt B.A., Hrycyshyn A.W. Topographical and ultrastructural investigation of the habenulo-interpeduncular pathway in the rat: a wheat germ agglutinin-horseradish peroxidase anterograde study. J Comp Neurol 1988, 275:117-127.
40. Kawaja M.D., Flumerfelt B.A., Hunt S.P., Hrycyshyn A.W. Substance P immunoreactivity in the rat interpeduncular nucleus: synaptic interactions between substance P-positive profiles and choline acetyltransferase- or glutamate decarboxylase-immunoreactive structures. Neuroscience 1991, 42:739-755.
41. Kieffer B.L., Evans C.J. Opioid receptors: from binding sites to visible molecules in vivo. Neuropharmacology 2009, 56(Suppl. 1):205-212.
42. Kieffer B.L., Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog Neurobiol 2002, 66:285-306.
43. Kim U. Topographic commissural and descending projections of the habenula in the rat. J Comp Neurol 2009, 513:173-187.
44. Kim U., Chang S.Y. Dendritic morphology, local circuitry, and intrinsic electrophysiology of neurons in the rat medial and lateral habenular nuclei of the epithalamus. J Comp Neurol 2005, 483:236-250.
45. Kitchen I., Slowe S.J., Matthes H.W., Kieffer B. Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. Brain Res 1997, 778:73-88.
46. Klemm W.R. Habenular and interpeduncularis nuclei: shared components in multiple-function networks. Med Sci Monit 2004, 10:RA261-RA273.
47. Kobayashi Y., Sano Y., Vannoni E., Goto H., Suzuki H., Oba A., Kawasaki H., Kanba S., Lipp H.P., Murphy N.P., Wolfer D.P., Itohara S. Genetic dissection of medial habenula-interpeduncular nucleus pathway function in mice. Front Behav Neurosci 2013, 7:17.
48. Konig M., Zimmer A.M., Steiner H., Holmes P.V., Crawley J.N., Brownstein M.J., Zimmer A. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 1996, 383:535-538.
49. Lammel S., Lim B.K., Ran C., Huang K.W., Betley M.J., Tye K.M., Deisseroth K., Malenka R.C. Input-specific control of reward and aversion in the ventral tegmental area. Nature 2012, 491:212-217.
50. Lapish C.C., Kroener S., Durstewitz D., Lavin A., Seamans J.K. The ability of the mesocortical dopamine system to operate in distinct temporal modes. Psychopharmacology (Berl) 2007, 191:609-625.
51. Lapish C.C., Seamans J.K., Chandler L.J. Glutamate-dopamine cotransmission and reward processing in addiction. Alcohol Clin Exp Res 2006, 30:1451-1465.
52. Larsen P.J. Distribution of substance P-immunoreactive elements in the preoptic area and the hypothalamus of the rat. J Comp Neurol 1992, 316:287-313.
53. Le Merrer J., Becker J.A., Befort K., Kieffer B.L. Reward processing by the opioid system in the brain. Physiol Rev 2009, 89:1379-1412.
54. Lecourtier L., Kelly P.H. A conductor hidden in the orchestra? Role of the habenular complex in monoamine transmission and cognition. Neurosci Biobehav Rev 2007, 31:658-672.
55. Lee Y.A., Goto Y. Neurodevelopmental disruption of cortico-striatal function caused by degeneration of habenula neurons. PLoS One 2011, 6:e19450.
56. Lee Y.A., Goto Y. Habenula and ADHD: convergence on time. Neurosci Biobehav Rev 2013, 37:1801-1809.
57. Lodge D.J., Grace A.A. The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc Natl Acad Sci U S A 2006, 103:5167-5172.
58. Lutz P.E., Kieffer B.L. Opioid receptors: distinct roles in mood disorders. Trends Neurosci 2013, 36:195-206.
59. Maldonado R., Girdlestone D., Roques B.P. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats. Neurosci Lett 1993, 156:135-140.
60. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 1994, 350:412-438.
61. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996, 383:819-823.
62. Menard J., Treit D. Lateral and medial septal lesions reduce anxiety in the plus-maze and probe-burying tests. Physiol Behav 1996, 60:845-853.
63. Michaud N., Couture R. Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists. Neuropeptides 2003, 37:345-354.
64. Mizoguchi H., Takagi H., Watanabe C., Yonezawa A., Sato T., Sakurada T., Sakurada S. Involvement of multiple micro-opioid receptor subtypes on the presynaptic or postsynaptic inhibition of spinal pain transmission. Peptides 2014, 51:15-25.
65. Moles A., Kieffer B.L., D'Amato F.R. Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science 2004, 304:1983-1986.
66. Morin L.P., Meyer-Bernstein E.L. The ascending serotonergic system in the hamster: comparison with projections of the dorsal and median raphe nuclei. Neuroscience 1999, 91:81-105.
67. Murtra P., Sheasby A.M., Hunt S.P., De Felipe C. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 2000, 405:180-183.
68. Norton A.B., Jo Y.S., Clark E.W., Taylor C.A., Mizumori S.J. Independent neural coding of reward and movement by pedunculopontine tegmental nucleus neurons in freely navigating rats. Eur J Neurosci 2011, 33:1885-1896.
69. Panchal V., Taraschenko O.D., Maisonneuve I.M., Glick S.D. Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine. Eur J Pharmacol 2005, 525:98-104.
70. Papaleo F., Kieffer B.L., Tabarin A., Contarino A. Decreased motivation to eat in mu-opioid receptor-deficient mice. Eur J Neurosci 2007, 25:3398-3405.
71. Pasternak G.W., Pan Y.X. Mu opioids and their receptors: evolution of a concept. Pharmacol Rev 2013, 65:1257-1317.
72. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego.
73. Porteous R., Petersen S.L., Yeo S.H., Bhattarai J.P., Ciofi P., de Tassigny X.D., Colledge W.H., Caraty A., Herbison A.E. Kisspeptin neurons co-express met-enkephalin and galanin in the rostral periventricular region of the female mouse hypothalamus. J Comp Neurol 2011, 519:3456-3469.
74. Pradhan A.A., Becker J.A., Scherrer G., Tryoen-Toth P., Filliol D., Matifas A., Massotte D., Gaveriaux-Ruff C., Kieffer B.L. In vivo delta opioid receptor internalization controls behavioral effects of agonists. PLoS One 2009, 4:e5425.
75. Qin C., Luo M. Neurochemical phenotypes of the afferent and efferent projections of the mouse medial habenula. Neuroscience 2009, 161:827-837.
76. Ren J., Qin C., Hu F., Tan J., Qiu L., Zhao S., Feng G., Luo M. Habenula "cholinergic" neurons co-release glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes. Neuron 2011, 69:445-452.
77. Ripley T.L., Gadd C.A., De Felipe C., Hunt S.P., Stephens D.N. Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology 2002, 43:1258-1268.
78. Root D.H., Ma S., Barker D.J., Megehee L., Striano B.M., Ralston C.M., Fabbricatore A.T., West M.O. Differential roles of ventral pallidum subregions during cocaine self-administration behaviors. J Comp Neurol 2013, 521:558-588.
79. Scherrer G., Tryoen-Toth P., Filliol D., Matifas A., Laustriat D., Cao Y.Q., Basbaum A.I., Dierich A., Vonesh J.L., Gaveriaux-Ruff C., Kieffer B.L. Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A 2006, 103:9691-9696.
80. Slowe S.J., Simonin F., Kieffer B., Kitchen I. Quantitative autoradiography of mu-, delta- and kappa1 opioid receptors in kappa-opioid receptor knockout mice. Brain Res 1999, 818:335-345.
81. Stamatakis A.M., Stuber G.D. Activation of lateral habenula inputs to the ventral midbrain promotes behavioral avoidance. Nat Neurosci 2012, 15:1105-1107.
82. Sutherland R.J. The dorsal diencephalic conduction system: a review of the anatomy and functions of the habenular complex. Neurosci Biobehav Rev 1982, 6:1-13.
83. Suzuki M., Narita M., Hasegawa M., Furuta S., Kawamata T., Ashikawa M., Miyano K., Yanagihara K., Chiwaki F., Ochiya T., Suzuki T., Matoba M., Sasaki H., Uezono Y. Sensation of abdominal pain induced by peritoneal carcinomatosis is accompanied by changes in the expression of substance P and mu-opioid receptors in the spinal cord of mice. Anesthesiology 2012, 117:847-856.
84. Terenzi M.G., Guimaraes F.S., Prado W.A. Antinociception induced by stimulation of the habenular complex of the rat. Brain Res 1990, 524:213-218.
85. Terenzi M.G., Prado W.A. Antinociception elicited by electrical or chemical stimulation of the rat habenular complex and its sensitivity to systemic antagonists. Brain Res 1990, 535:18-24.
86. Trang T., Sutak M., Quirion R., Jhamandas K. The role of spinal neuropeptides and prostaglandins in opioid physical dependence. Br J Pharmacol 2002, 136:37-48.
87. Viswanath H., Carter A.Q., Baldwin P.R., Molfese D.L., Salas R. The medial habenula: still neglected. Front Hum Neurosci 2013, 7:931.
88. Yamaguchi T., Danjo T., Pastan I., Hikida T., Nakanishi S. Distinct roles of segregated transmission of the septo-habenular pathway in anxiety and fear. Neuron 2013, 78:537-544.
89. Yang L.M., Yu L., Jin H.J., Zhao H. Substance P receptor antagonist in lateral habenula improves rat depression-like behavior. Brain Res Bull 2014, 100:22-28.
90. Zhou Q., Liu Z., Ray A., Huang W., Karlsson K., Nyberg F. Alteration in the brain content of substance P (1-7) during withdrawal in morphine-dependent rats. Neuropharmacology 1998, 37:1545-1552.
91. Zimmer A., Zimmer A.M., Baffi J., Usdin T., Reynolds K., Konig M., Palkovits M., Mezey E. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci U S A 1998, 95:2630-2635.